GSK - GlaxoSmithKline PLC ADR - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GSK is currently covered by 6 analysts with an average price target of $31.29. This is a potential upside of $-5.88 (-15.82%) from yesterday's end of day stock price of $37.17.

GlaxoSmithKline PLC ADR's activity chart (see below) currently has 127 price targets and 86 ratings on display. The stock rating distribution of GSK is 33.33% HOLD and 66.67% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 19.94% with an average time for these price targets to be met of 304.33 days.

Highest price target for GSK is $45, Lowest price target is $41, average price target is $43.33.

Most recent stock forecast was given by KERRY HOLFORD from BERENBERG on 02-Dec-2024. First documented stock forecast 28-Jul-2014.

Currently out of the existing stock ratings of GSK, 3 are a HOLD (33.33%), 6 are a BUY (66.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$41

$1.93 (4.94%)

5 months 5 days ago
(02-Dec-2024)

0/1 (0%)

$6.69 (19.50%)

Hold

$53

5 months 25 days ago
(12-Nov-2024)

2/4 (50%)

$15.58 (41.64%)

379

Buy

9 months 6 days ago
(01-Aug-2024)

1/13 (7.69%)

$-10.5 (-32.65%)

64

Buy

$45

$5.93 (15.18%)

$47

9 months 21 days ago
(16-Jul-2024)

1/3 (33.33%)

$6.9 (18.11%)

2259

Buy

$19.52

1 years 2 months 24 days ago
(13-Feb-2024)

0/3 (0%)

$-13.88 (-41.56%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GSK (GlaxoSmithKline PLC ADR) average time for price targets to be met?

On average it took 304.33 days on average for the stock forecasts to be realized with a an average price target met ratio 19.94

Which analyst has the current highest performing score on GSK (GlaxoSmithKline PLC ADR) with a proven track record?

JUSTIN SMITH

Which analyst has the most public recommendations on GSK (GlaxoSmithKline PLC ADR)?

Justin Smith works at SOCGEN and has 3 price targets and 2 ratings on GSK

Which analyst is the currently most bullish on GSK (GlaxoSmithKline PLC ADR)?

John Eade with highest potential upside - $5.93

Which analyst is the currently most reserved on GSK (GlaxoSmithKline PLC ADR)?

Eric Le Berrigaud with lowest potential downside - -$22.45

GlaxoSmithKline PLC ADR in the News

GSK (LON:GSK) Will Pay A Dividend Of £0.16

The board of GSK plc (LON:GSK) has announced that it will pay a dividend on the 10th of July, with investors receiving £0.16 per share. This will take the dividend yield to an attractive 4.2%, providing a nice boost to shareholder returns. Our free stock report includes 4 warning signs investors should be aware of...

GSK PLC (GSK) Q1 2025 Earnings Call Highlights: Strong Specialty Medicines Growth Amid Vaccine ...

Group Sales: Up 4% in Q1 2025. Operating Profit: Increased by 5%. Core Earnings Per Share: Rose 5% to GBP 0.449. Specialty Medicines Sales: Up 17%. Vaccine Sales: Down 6%. Cash Generated from Operations: Over GBP 1 billion. Dividend: Increased to GBP 0.16 per share. Share Buyback Program: GBP 2 billion commenced. Sales in Q1:...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?